Human in vivo NMR spectroscopy in diagnostic medicine: clinical tool or research probe?
暂无分享,去创建一个
[1] J. Ackerman,et al. Determination of intact-tissue glycerophosphorylcholine levels by quantitative 31P nuclear magnetic resonance spectroscopy and correlation with spectrophotometric quantification. , 1985, Analytical biochemistry.
[2] W J Lorenz,et al. Impact of hyperthermic regional perfusion therapy on cell metabolism of malignant melanoma monitored by 31P MR spectroscopy. , 1988, Magnetic resonance imaging.
[3] P A Bottomley,et al. The fate of inorganic phosphate and pH in regional myocardial ischemia and infarction: A noninvasive 31P NMR study , 1987, Magnetic resonance in medicine.
[4] W. J. Lorenz,et al. Monitoring human tumor response to therapy by means of P-31 MR spectroscopy. , 1988, Radiology.
[5] P R Luyten,et al. Observation of metabolites in the human brain by MR spectroscopy. , 1986, Radiology.
[6] M. Tattersall,et al. Hyperlipidemia as a biochemical basis of magnetic resonance plasma test for cancer , 1988, NMR in biomedicine.
[7] D. J. Hayes,et al. A mitochondrial encephalomyopathy A combined 31P magnetic resonance and biochemical investigation , 1985, Journal of the Neurological Sciences.
[8] P. E. Hanley,et al. Localization of metabolites in animals using 31P topical magnetic resonance , 1980, Nature.
[9] J. M. Carr,et al. Detection of malignant tumors. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma. , 1986, The New England journal of medicine.
[10] S. Levine,et al. Prolonged deterioration of ischemic brain energy metabolism and acidosis associated with hyperglycemia: Human cerebral infarction studied by serial 31P NMR spectroscopy , 1988, Annals of neurology.
[11] P A Bottomley,et al. Noninvasive study of high-energy phosphate metabolism in human heart by depth-resolved 31P NMR spectroscopy. , 1985, Science.
[12] Christopher J. Hardy,et al. PROGRESS in efficient three-dimensional spatially localized in vivo31P NMR spectroscopy using multidimensional spatially selective (ϱ) pulses , 1987 .
[13] E. Reynolds,et al. Investigation of cerebral energy metabolism in newborn infants by phosphorus nuclear magnetic resonance spectroscopy. , 1985, Clinics in perinatology.
[14] P. Bottomley,et al. Assessment of pharmacological treatment of myocardial infarction by phosphorus-31 NMR with surface coils. , 1981, Science.
[15] H. Sostman,et al. NMR in cancer. I. High resolution spectroscopy of tumors. , 1984, Magnetic resonance imaging.
[16] T. Ng,et al. In vivo MR spectroscopy of human subjects with a 1.4-T whole-body MR imager. , 1986, Radiology.
[17] G. Radda,et al. The study of human organs by phosphorus-31 topical magnetic resonance spectroscopy. , 1987, The British journal of radiology.
[18] M Dyne,et al. A proteolipid in cancer cells is the origin of their high‐resolution NMR spectrum , 1986, FEBS letters.
[19] E Mok,et al. High resolution proton magnetic resonance spectroscopy of human brain and liver. , 1987, Magnetic resonance imaging.
[20] G. Radda,et al. STUDY OF HEREDITARY FRUCTOSE INTOLERANCE BY USE OF 31P MAGNETIC RESONANCE SPECTROSCOPY , 1987, The Lancet.
[21] D. Gadian,et al. 31P NMR examination of two patients with NADH-CoQ reductase deficiency , 1982, Nature.
[22] G K Radda,et al. The use of NMR spectroscopy for the understanding of disease. , 1986, Science.
[23] B. Chance,et al. An Approach to the Problem of Metabolic Heterogeneity in Brain: Ischemia and Reflow after Ischemia a , 1987, Annals of the New York Academy of Sciences.
[24] F. Lehmann-Horn,et al. In vivo P‐NMR spectroscopy: Muscle energy exchange in paramyotonia patients , 1985, Muscle & nerve.
[25] R. C. Reeves,et al. Proton NMR spectroscopy in myocardial ischemic insult , 1987, Magnetic resonance in medicine.
[26] G. Radda,et al. Non Invasive Measurement of Poly-Unsaturated Fatty-Acids in Human Fat by C-13 Magnetic-Resonance Spectroscopy , 1985 .
[27] W. Edelstein,et al. The intrinsic signal‐to‐noise ratio in NMR imaging , 1986, Magnetic resonance in medicine.
[28] B. Clark,et al. Phosphorus Magnetic Resonance Spectroscopy Studies of the Role of Mitochondria in the Disease Process a , 1986, Annals of the New York Academy of Sciences.
[29] R. C. Reeves,et al. Monitoring the bioenergetics of cardiac allograft rejection using in vivo P-31 nuclear magnetic resonance spectroscopy. , 1987, Journal of the American College of Cardiology.
[30] G. Radda,et al. Muscle metabolism in patients with peripheral vascular disease investigated by 31P nuclear magnetic resonance spectroscopy. , 1986, Clinical science.
[31] E M Chance,et al. Mathematical analysis of isotope labeling in the citric acid cycle with applications to 13C NMR studies in perfused rat hearts. , 1983, The Journal of biological chemistry.
[32] M. Delivoria-Papadopoulos,et al. Unique aspects of human newborn cerebral metabolism evaluated with phosphorus nuclear magnetic resonance spectroscopy , 1984, Annals of neurology.
[33] P. Luyten,et al. Image‐Guided Localized 1 H and 31P NMR Spectroscopy of Humans , 1987, Annals of the New York Academy of Sciences.
[34] Jerry D. Glickson,et al. 31P NMR spectroscopy of in vivo tumors , 1982 .
[35] J. Sargentoni,et al. Four‐dimensional phosphorus‐31 chemical shift imaging of carcinoid metastases in the liver , 1988, NMR in biomedicine.
[36] C J Hardy,et al. Rapid 31P spectroscopy on a 4‐T whole‐body system , 1988, Magnetic resonance in medicine.
[37] B. Chance,et al. Evaluation of energy metabolism in skeletal muscle of patients with heart failure with gated phosphorus-31 nuclear magnetic resonance. , 1985, Circulation.
[38] A. S. Hall,et al. Four‐Dimensional Chemical Shift MR Imaging of Phosphorus Metabolites of Normal and Diseased Human Liver , 1988, Journal of computer assisted tomography.
[39] G K Radda,et al. Examination of a case of suspected McArdle's syndrome by 31P nuclear magnetic resonance. , 1981, The New England journal of medicine.
[40] J. Shapiro,et al. P‐31 NUCLEAR MAGNETIC RESONANCE SPECTROSCOPIC EVALUATION OF HETEROTOPIC CARDIAC ALLOGRAFT REJECTION IN THE RAT , 1987, Transplantation.
[41] P. Lauterbur,et al. The sensitivity of the zeugmatographic experiment involving human samples , 1979 .
[42] T. Nakada,et al. Noninvasive In Vivo Demonstration of 2‐Fluoro‐2‐Deoxy‐d‐Glucose Metabolism Beyond the Hexokinase Reaction in Rat Brain by 19F Nuclear Magnetic Resonance Spectroscopy , 1986, Journal of neurochemistry.
[43] Graeme M. Bydder,et al. Localized phosphorus-31 NMR spectroscopy of normal and pathological human organs in vivo using phase-encoding techniques , 1987 .
[44] C Arús,et al. Proton nuclear magnetic resonance spectra of excised rat brain. Assignment of resonances. , 1985, Physiological chemistry and physics and medical NMR.
[45] R. Sepponen,et al. A Method for Chemical Shift Imaging: Demonstration of Bone Marrow Involvement with Proton Chemical Shift Imaging , 1984, Journal of computer assisted tomography.
[46] G. Radda,et al. Measurement of Phosphocreatine to ATP Ratio in Normal and Diseased Human Heart by 31P Magnetic Resonance Spectroscopy Using the Rotating Frame‐Depth Selection Technique a , 1987, Annals of the New York Academy of Sciences.
[47] Robert G. Shulman,et al. Volume-selected proton spectroscopy in the human brain , 1988 .
[48] R. Shulman,et al. In vivo carbon-13 nuclear magnetic resonance studies of heart metabolism. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[49] G K Radda,et al. Nuclear magnetic resonance studies of forearm muscle in Duchenne dystrophy. , 1982, British medical journal.
[50] W. Edelstein,et al. Proton imaging and phosphorus spectroscopy in a malignant glioma. , 1985, AJNR. American journal of neuroradiology.
[51] P A Bottomley,et al. Noninvasive detection and monitoring of regional myocardial ischemia in situ using depth-resolved 31P NMR spectroscopy. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[52] R. Shulman,et al. Natural abundance Carbon-13 nuclear magnetic resonance spectroscopy of liver and adipose tissue of the living rat. , 1983, Biochemistry.
[53] H C Charles,et al. Human in vivo phosphate metabolite imaging with 31P NMR , 1988, Magnetic resonance in medicine.
[54] D. Gadian,et al. Study of human kidneys prior to transplantation by phosphorus nuclear magnetic resonance , 1982 .
[55] D. Arnold,et al. MR image-guided P-31 MR spectroscopy in the evaluation of brain tumor treatment. , 1987, Radiology.
[56] P. Bottomley,et al. Cerebral energy metabolism in rats studied by phosphorus nuclear magnetic resonance using surface coils. , 1982, Magnetic resonance imaging.
[57] D. R. Wilkie,et al. CEREBRAL ENERGY METABOLISM STUDIED WITH PHOSPHORUS NMR SPECTROSCOPY IN NORMAL AND BIRTH-ASPHYXIATED INFANTS , 1984, The Lancet.
[58] B. Chance,et al. Detection of muscle injury in humans with 31‐P magnetic resonance spectroscopy , 1988, Muscle & nerve.
[59] C. Dumoulin,et al. Lipid and water suppression by selective 1H homonuclear polarization transfer , 1987, Magnetic resonance in medicine.
[60] R. Shulman,et al. Structure and metabolism of mammalian liver glycogen monitored by carbon-13 nuclear magnetic resonance. , 1983, Biochemistry.
[61] L. Bolinger,et al. Phosphorylethanolamine ‐ the major constituent of the phosphomonoester peak observed by 31P‐NMR on developing dog brain , 1984, FEBS letters.
[62] Barr,et al. Classification of Human-Tumors by High-Resolution Magnetic-Resonance Spectroscopy , 1986 .
[63] M W Weiner,et al. The promise of magnetic resonance spectroscopy for medical diagnosis. , 1988, Investigative radiology.
[64] J. Wittenberg,et al. Liver metastases: detection by phase-contrast MR imaging. , 1986, Radiology.
[65] D. Arnold,et al. EXCESSIVE INTRACELLULAR ACIDOSIS OF SKELETAL MUSCLE ON EXERCISE IN A PATIENT WITH A POST-VIRAL EXHAUSTION/FATIGUE SYNDROME A 31P Nuclear Magnetic Resonance Study , 1984, The Lancet.
[66] D. Delpy,et al. IMPAIRED ENERGY METABOLISM IN BRAINS OF NEWBORN INFANTS WITH INCREASED CEREBRAL ECHODENSITIES , 1986, The Lancet.
[67] W. S. Snyder,et al. Report of the task group on reference man , 1979, Annals of the ICRP.
[68] R G Shulman,et al. 1H homonuclear editing of rat brain using semiselective pulses. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[69] K. Uğurbil,et al. NMR chemical shift imaging in three dimensions. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[70] P E Wright,et al. Assignment of methylene proton resonances in NMR spectra of embryonic and transformed cells to plasma membrane triglyceride. , 1986, The Journal of biological chemistry.
[71] J. Maris,et al. Bioenergetic heterogeneity of human mitochondrial myopathies , 1987, Neurology.
[72] W. A. Adams,et al. In vivo solvent-suppressed localized hydrogen nuclear magnetic resonance spectroscopy: a window to metabolism? , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[73] T. Ng,et al. Response of a non-Hodgkin lymphoma to 60Co therapy monitored by 31P MRS in situ. , 1987, International journal of radiation oncology, biology, physics.
[74] 31P imaging of in Vivo creatine kinase reaction rates , 1987 .
[75] D. Arnold,et al. Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy , 1985, Annals of neurology.
[76] J. Griffiths,et al. 5-fluorouracil metabolism monitored in vivo by 19F NMR. , 1984, British Journal of Cancer.
[77] J. Heiken,et al. Fatty infiltration of the liver: evaluation by proton spectroscopic imaging. , 1985, Radiology.
[78] R. Herfkens,et al. Altered phosphate metabolism in myocardial infarction: P-31 MR spectroscopy. , 1987, Radiology.
[79] S. Frostick,et al. 31P nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with congestive heart failure. , 1987, The American journal of cardiology.
[80] M. Tattersall,et al. PROTEOLIPID IDENTIFIED BY MAGNETIC RESONANCE SPECTROSCOPY IN PLASMA OF A PATIENT WITH BORDERLINE OVARIAN TUMOUR , 1987, The Lancet.
[81] J. Ra,et al. In Vivo NMR Imaging of Sodium‐23 in the Human Head , 1985, Journal of computer assisted tomography.
[82] Y Itzchak,et al. Breast tumors: evaluation with P-31 MR spectroscopy. , 1986, Radiology.
[83] G. Radda,et al. Hypophosphataemic osteomalacia and myopathy: studies with nuclear magnetic resonance spectroscopy. , 1984, Clinical science.
[84] W A Murphy,et al. Fatty infiltration of the liver: demonstration by proton spectroscopic imaging. Preliminary observations. , 1984, Radiology.
[85] Paul A. Bottomley,et al. Depth-resolved surface-coil spectroscopy (DRESS) for in Vivo 1H, 31P, and 13C NMR , 1984 .
[86] D. Gadian,et al. Mapping of metabolites in whole animals by 31P NMR using surface coils , 1980, Nature.
[87] R. Shulman,et al. Effect of Hypoglycemic Encephalopathy upon Amino Acids, High‐Energy Phosphates, and pHi in the Rat Brain In Vivo: Detection by Sequential 1H and 31P NMR Spectroscopy , 1985, Journal of neurochemistry.
[88] Hart,et al. Anatomy and metabolism of the normal human brain studied by magnetic resonance at 1.5 Tesla. , 1984, Radiology.
[89] R G Shulman,et al. Homonuclear 1H double-resonance difference spectroscopy of the rat brain in vivo. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[90] Peter Styles,et al. Towards biochemical imaging , 1980 .
[91] G. Radda,et al. Quantitative studies of human cardiac metabolism by 31P rotating-frame NMR. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[92] D. Arnold,et al. Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy. , 1985, Biochemical Society transactions.
[93] R G Shulman,et al. High-resolution 1H nuclear magnetic resonance study of cerebral hypoxia in vivo. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[94] D. Wilkie,et al. CLINICAL USE OF NUCLEAR MAGNETIC RESONANCE IN THE INVESTIGATION OF MYOPATHY , 1982, The Lancet.
[95] B. Chance,et al. 31P nuclear magnetic resonance spectroscopic investigation of human neuroblastoma in situ. , 1985, The New England journal of medicine.
[96] B. Chance,et al. Muscle energy metabolism in human phosphofructokinase deficiency as recorded by 31P nuclear magnetic resonance spectroscopy , 1987, Annals of neurology.
[97] Britton Chance,et al. An in vivo phosphorus nuclear magnetic resonance study of the variations with age in the phosphodiers' content of human muscle , 1988, Mechanisms of Ageing and Development.
[98] B. Chance,et al. 31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[99] N. Minshew,et al. 31P Nuclear Magnetic Resonance Studies of Phosphoglyceride Metabolism in Developing and Degenerating Brain: Preliminary Observations , 1987, Journal of neuropathology and experimental neurology.
[100] D. D'avignon,et al. Correlation between the anaesthetic effect of halothane and saturable binding in brain , 1987, Nature.
[101] B. Drayer,et al. Chronic adult cerebral infarction studied by phosphorus NMR spectroscopy. , 1986, Radiology.
[102] D. Doddrell,et al. Use of high resolution in vivo volume selected 1H-magnetic resonance spectroscopy to investigate leukemia in humans. , 1987, Cancer research.
[103] Roger J. Ordidge,et al. Image-selected in Vivo spectroscopy (ISIS). A new technique for spatially selective nmr spectroscopy , 1986 .
[104] B. Chance,et al. 31P NMR studies of control of mitochondrial function in phosphofructokinase-deficient human skeletal muscle. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[105] J. S. Cohen,et al. Phospholipid metabolism in cancer cells monitored by 31P NMR spectroscopy. , 1987, The Journal of biological chemistry.
[106] M. Bárány,et al. INCREASED GLYCEROL-3-PHOSPHORYLCHOUNE IN POST-MORTEM ALZHEIMER'S BRAIN , 1985, The Lancet.
[107] B. Chance,et al. Phosphorus Magnetic Resonance Spectroscopy of Partially Blocked Muscle Glycolysis: An In Vivo Study of Phosphoglycerate Mutase Deficiency , 1987 .
[108] W. Derbyshire,et al. High Resolution NMR , 1966, Nature.
[109] C. Burt,et al. A hypothesis: noncyclic phosphodiesters may play a role in membrane control. , 1984, Biochemical medicine.
[110] J. Cook,et al. Muscle fatigue in McArdle's disease studied by 31P-NMR: effect of glucose infusion. , 1985, Journal of applied physiology.
[111] D. Wilkie,et al. Muscle energy metabolism in duchenne dystrophy studied by 31P‐NMR: Controlled trials show no effect of allopurinol or ribose , 1985, Muscle & nerve.